CAS Qingdao team develop single-cell precision diagnosis for Helicobacter pylori from gastric biopsy
more insights
R&D institutions
- CAS Institute of Oceanology http://english.qdio.cas.cn/Internation/gjwyh/
- CAS Center for Ocean Megascience http://www.coms.ac.cn/home/
- CAS Qingdao Institute of Bioenergy and Environmental Technology QIBEBT http://www.qibebt.cas.cn
- Shandong Energy Institute https://english.cas.cn/Special_Reports/Dual_Carbon_CAS_in_Action/Org/202204/t20220402_303477.shtml
- Shandong University National Research Center for Colloidal Materials https://nccm.sdu.edu.cn/english/
- Qingdao Haier Institute of Industrial Intelligence Co., Ltd. http://www.iecz.cn/content.action?formId=52&dataId=132&columnId=25&parentId=3
- Hisense Medical https://medical.hisense.com/html/about_us/rd/
- Vland Biotech http://www.vlandgroup.com/en/view/64.html
Universities in Qingdao
- China University of Petroleum https://english.upc.edu.cn
- Ocean University of China http://eweb.ouc.edu.cn
- Shandong University of Science and Technology https://en.sdust.edu.cn
- Qingdao University of Science and Technology https://en.qust.edu.cn
- Qingdao University of Technology https://en.wikipedia.org/wiki/Qingdao_University_of_Technology
- Qingdao Agricultural University https://en.qau.edu.cn
Photo: Haier Global Creative Research Center in Qingdao
http://www.vlandbiochem.com/article-5545-10977.html
On March 14, 2024, Evonik Vland Biotech (Shandong) Co., Ltd. was put into operation in Qingdao, China. The joint venture of Evonik China Co., Ltd. and Shandong Vland Biotech Co., Ltd. aims to develop and expand gut health solutions products including probiotics for farm animals in China. Evonik holds the majority with a share of 55 %.
Head of Evonik’s life science division Nutrition & Care, the Animal Nutrition business line is Johann-Caspar Gammelin.
The joint venture is headquartered in Vland Biotech Innovation Park in Qingdao, China, and Vland’s production facilities in Binzhou, Shandong Province, China., will be utilized.
“Benefiting from the strong innovation capabilities, applied technology expertise and excellent reputation of the two parent companies, we will deliver innovative products and solutions to the market, and create more value for our customers,” says Dr. Wang Xu, general manager of Evonik Vland Biotech (Shandong) Co., Ltd.
http://english.qibebt.cas.cn/ne/ns/202310/t20231027_397294.html
On Oct. 27, 2024, Prof. Juergen Popp Speaks, director of the Leibniz Institute of Photonic Technology and chair for Physical Chemistry at Friedrich-Schiller University, gave a talk at QIBEBT Distinguished Expert Forum and Visits Single-Cell Center on “Translational Biophotonics – Raman spectroscopy and AI a game changer !?” Popp elucidated the innovative technologies and potential applications of Raman spectroscopy in biophotonics, particularly its extensive use in clinical diagnostics. He emphasized the potential of multimodal methods combining Raman spectroscopy with other spectroscopic/optical technologies and how Raman can address today’s medical challenges, such as early cancer diagnosis and personalized treatments.
The visit was part of the Sino-German Scientific Partnership Program funded by the National Natural Science Foundation of China.
Back to …
